LALindsay N. Avolio

Lindsay N. Avolio

*This is an algorithmically generated author record based on publicly available information.

Lindsay N. Avolio has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Elimination of Legionella colonization in a hospital water system: evidence from 23 years of chlorine dioxide use

    by Natalie G. Exum, Lindsay N. Avolio, Gregory Bova, Clare Rock, Melanie S. Curless, Lisa L. Maragakis, Kellogg J. Schwab

    A hospital water system colonized with Legionella bacteria (three of four buildings, with > 50% of positive samples) was able to reduce detections to 2 was iteratively added first to the cold-water and then hot-water systems followed by pipe replacements (n = 6835 total samples).


  • Open Access

    The Pregnancy, Arsenic, and Immune Response (PAIR) Study in rural northern Bangladesh

    by Lindsay N. Avolio, Tyler J. S. Smith, Ana Navas‐Acien, Kate Kruczynski, Nora Pisanic, Pranay R. Randad, Barbara Detrick, Rebecca C. Fry, Alexander van Geen, Walter Goessler, et al.

    Background: Arsenic exposure and micronutrient deficiencies may alter immune reactivity to influenza vaccination in pregnant women, transplacental transfer of maternal antibodies to the foetus, and maternal and infant acute morbidity.Objectives: The Pregnancy, Arsenic, and Immune Response (PAIR) Study was designed to assess whether arsenic exposure and micronutrient deficiencies alter maternal and newborn immunity and acute morbidity following maternal seasonal influenza vaccination during pregnancy.Population: The PAIR Study recruited pregnant women across a large rural study area in Gaibandha District, northern Bangladesh, 2018–2019.Design: Prospective, longitudinal pregnancy and birth cohort.Methods: We conducted home visits to enrol pregnant women in the late first or early second trimester (11–17 weeks of gestational age). Women received a quadrivalent seasonal inactivated influenza vaccine at enrolment. Follow‐up included up to 13 visits between enrolment and 3 months postpartum. Arsenic was measured in drinking water and maternal urine. Micronutrient deficiencies were assessed using plasma biomarkers. Vaccine‐specific antibody titres were measured in maternal and infant serum. Weekly telephone surveillance ascertained acute morbidity symptoms in women and infants.Preliminary Results: We enrolled 784 pregnant women between October 2018 and March 2019. Of 784 women who enrolled, 736 (93.9%) delivered live births and 551 (70.3%) completed follow‐up visits to 3 months postpartum. Arsenic was detected (≥0.02 μg/L) in 99.7% of water specimens collected from participants at enrolment. The medians (interquartile ranges) of water and urinary arsenic at enrolment were 5.1 (0.5, 25.1) μg/L and 33.1 (19.6, 56.5) μg/L, respectively. Water and urinary arsenic were strongly correlated (Spearman's ⍴ = 0.72) among women with water arsenic ≥ median but weakly correlated (⍴ = 0.17) among women with water arsenic < median.Conclusions: The PAIR Study is well positioned to examine the effects of low‐moderate arsenic exposure and micronutrient deficiencies on immune outcomes in women and infants.Registration: NCT03930017.


  • Open Access

    Cohort profile: The Pregnancy, Arsenic, and Immune Response (PAIR) Study, a longitudinal pregnancy and birth cohort in rural northern Bangladesh

    by Lindsay N. Avolio, Tyler J. S. Smith, Ana Navas-Acien, Kate Kruczynski, Nora Pisanic, Pranay R. Randad, Barbara Detrick, Rebecca C. Fry, Alexander van Geen, Walter Goessler, et al.

    Purpose Arsenic exposure and micronutrient deficiencies may alter immune reactivity to influenza vaccination in pregnant women, transplacental transfer of maternal antibodies to the fetus, and maternal and infant acute morbidity. The Pregnancy, Arsenic, and Immune Response (PAIR) Study is a longitudinal pregnancy and birth cohort designed to assess whether arsenic exposure and micronutrient deficiencies alter maternal or newborn immunity and acute morbidity following maternal seasonal influenza vaccination during pregnancy. Participants We enrolled 784 pregnant women in rural Gaibandha District in northern Bangladesh between October 2018 and March 2019. Women received a quadrivalent seasonal inactivated influenza vaccine at enrollment in the late first or early second trimester between 11 and 17 weeks of gestational age. Follow-up included up to 13 visits between enrollment and three months postpartum as well as weekly telephone surveillance to ascertain influenza-like illness and other acute morbidity symptoms in women and infants. Tube well drinking water and urine specimens were collected to assess arsenic exposure. Of 784 women who enrolled, 736 (93.9%) delivered live births and 551 (70.3%) completed follow-up visit to three months postpartum. Findings to Date Arsenic was ≥0.02 µg/L in 97.9% of water specimens collected from participants at enrollment. The medians (interquartile ranges) of water and urinary arsenic were 5.1 (0.5-25.1) µg/L and 33.1 (19.6-56.5) µg/L, respectively. Water and urinary arsenic were strongly correlated (Spearman’s ρ=0.72) among women with water arsenic ≥ median but weakly correlated (ρ=0.18) among women with water arsenic < median. Future Plans The PAIR Study is well positioned to examine the effects of low-moderate arsenic exposure and micronutrient deficiencies on immune outcomes in women and infants. Registration NCT03930017

  • Impacts of a changing earth on microbial dynamics and human health risks in the continuum between beach water and sand

    by Chelsea J. Weiskerger, João Brandão, Warish Ahmed, Asli Aslan, Lindsay Avolio, Brian D. Badgley, Alexandria B. Boehm, Thomas A. Edge, Jay M. Fleisher, Christopher D. Heaney, et al.